JAMA Dermatology : Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Interview with Paul Nghiem, MD, PhD, author of Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. Hosted by Adewole S. Adamson, MD, MPP. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 23, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Racial Disparity in Survival Outcomes for Early Hormone Receptor –Positive Breast Cancer
Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 17, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
259: Sea Sawdust
Mark Martin returns to TWiM for a discussion of the frightening global burden of bacterial antibiotic resistance, and a solution to the problem of daylight nitrogen fixation in a cyanobacterium, despite the incompatibility of nitrogenase with oxygen produced during photosynthesis. Become a patron of TWiM. Links for this episode: Global bacterial antimicrobial resistance (Nat Micro) Cancer moon shot (NCI) When antibiotics don’t work (TED) Cyanobacterium buoyancy (Nat Micro) Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Send your microbiology questions and comments to twim@microbe...
Source: This Week in Virology - MP3 Edition - February 11, 2022 Category: Virology Authors: Vincent Racaniello, Elio Schaechter, Michele Swanson, Michael Schmidt, Mark O. Martin Source Type: podcasts
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Diabetes Core Update – February 2022
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 29, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
JAMA Oncology : Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy
Interview with Laurent Dercle, MD, PhD, author of Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 20, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC
Interview with Heather Jacene MD, and Jonathan D. Schoenfeld, MD, MPH, authors of Use of Fluoro-[F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers Hosted by Joseph P. Bradley, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 20, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Medical Oncology Depression Screening for Breast Cancer, Anesthesia Choice and Postoperative Delirium After Hip Fracture Surgery, Maternal Hormone Contraception and CNS Tumors in Children, and more
Editor’s Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 4, 2022 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 4, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Oncology : Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - December 23, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
In conversation with... Nick James
Nick James discusses the key messages of the recent report from the STAMPEDE trial platform and the success of this platform in advancing the treatment of prostate cancer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - December 23, 2021 Category: General Medicine Authors: The Lancet Source Type: podcasts
Can music interventions benefit people with cancer?
Music therapy is used for a variety of conditions and several Cochrane Reviews examine its effects. A team of music therapists with expertise in the use of music therapy with medical patients updated their review for cancer patients in October 2021. Joke Bradt from the department of Creative Arts Therapies at Drexel University in Philadelphia, USA tells us what they found in this Evidence Pod. She conducted the review with Cheryl Dileo from Temple University in Philadelphia, Katherine Myers-Coffman from Molloy College in Rockville Center, and Jacelyn Biondo, postdoctoral fellow in the department of Creative Arts Therapies ...
Source: Podcasts from The Cochrane Library - November 29, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
CAR T-cell therapy for people with diffuse large B-cell lymphoma which returns after treatment or no longer responds to treatment
Diffuse large B-cell lymphoma is a fast-growing cancer of the lymphatic system. A new Cochrane Review from September 2021 looks at the evidence on the effects of one treatment, chimeric antigen receptor (CAR) T-cell therapy for people whose disease relapses or does not respond to other treatments. We asked the lead author, Moritz Ernst from the Faculty of Medicine and University Hospital Cologne in Germany to tell us what they found. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 29, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
Wildfires could threaten ozone layer, and vaccinating against tick bites
Could wildfires be depleting the ozone all over again? Staff Writer Paul Voosen talks with host Sarah Crespi about the evidence from the Polarstern research ship for wildfire smoke lofting itself high into the stratosphere, and how it can affect the ozone layer once it gets there.
Next, we talk ticks—the ones that bite, take blood, and can leave you with a nasty infection. Andaleeb Sajid, a staff scientist at the National Cancer Institute, joins Sarah to talk about her Science Translational Medicine paper describing an mRNA vaccine intended to reduce the length of tick bites to before the pests can transmit diseases...
Source: Science Magazine Podcast - November 18, 2021 Category: Science Authors: Science Magazine Source Type: podcasts
Wildfires could threaten ozone layer, and vaccinating against tick bites
Could wildfires be depleting the ozone all over again? Staff Writer Paul Voosen talks with host Sarah Crespi about the evidence from the Polarstern research ship for wildfire smoke lofting itself high into the stratosphere, and how it can affect the ozone layer once it gets there.
Next, we talk ticks—the ones that bite, take blood, and can leave you with a nasty infection. Andaleeb Sajid, a staff scientist at the National Cancer Institute, joins Sarah to talk about her Science Translational Medicine paper describing an mRNA vaccine intended to reduce the length of tick bites to before the pests can transmit diseases to ...
Source: Science Magazine Podcast - November 18, 2021 Category: Science Authors: Science Magazine Source Type: podcasts
JAMA Oncology : Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 18, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
